An end-to-end solution to take your product from concept to compound to cure.
Integrated Drug Development Solutions
Over the last 40 years, we’ve built up our world-class ecosystem of expertise and capabilities to offer you an end-to-end solution to get your product from concept to compound to cure. We’ve seen—and done—it all. We’ve earned the knowledge that empowers us to proactively prevent common challenges and unexpected hurdles that could get in-between you and successful outcomes. No matter where you are in your product lifecycle, our Integrated Drug Development Solutions will partner with you to safely and effectively guide you to success.
Learn more about our Integrated Drug Development Solutions:Early Phase Solutions Phase II-III Real World Solutions
PRA Talks COVID-19 Impact on Rare Disease Clinical Trials with Patient Advocates
PRA’s Center for Rare Diseases understands that clinical trials are both a source of hope and care for people affected by a rare disease. The impact…
Risk-Based Approach to Clinical Development
PRA’s risk-based approach to clinical development represents a comprehensive approach to clinical study risk management and includes centralized…
Center for Global Drug Development Fact Sheet
PRA’s Center for Global Drug Development (CGDD) knows what it takes to deliver new drugs to the market. Our leaders ensure that all services focus on…